Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vicarious SurgicalRBOT +1.19% Equity-to-Asset is 0.28 as of Mar. 2026, which is 61% below its 10-year median of 0.72. The stock has 2 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Vicarious Surgical ranks worse than 85.31% on this metric.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Vicarious Surgical Equity-to-Asset Related Terms
Vicarious Surgical Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Vicarious Surgical's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RBOT vs SSKN, VTAK, ODYY: Equity-to-Asset Comparison
For the Medical Devices subindustry, Vicarious Surgical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vicarious Surgical Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Vicarious Surgical's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Vicarious Surgical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vicarious Surgical (RBOT) has a Equity-to-Asset of 0.28 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Vicarious Surgical and its competitors. This is 61% below median its historical median of 0.72. Over the past decade, Vicarious Surgical's Equity-to-Asset has ranged from 0.05 to 0.95. According to the industry distribution chart, Vicarious Surgical ranks #726 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 85.3%.
Is Vicarious Surgical's Equity-to-Asset too high?
Vicarious Surgical's current Equity-to-Asset of 0.28 is 61% below median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.95. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Vicarious Surgical's value of 0.28 is 56.3% below this industry median. Based on the distribution chart, Vicarious Surgical ranks #726 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Vicarious Surgical's Equity-to-Asset compare to SSKN and VTAK?
According to the Medical Devices & Instruments industry distribution chart, Vicarious Surgical ranks #726 out of 851 companies for Equity-to-Asset. This places Vicarious Surgical in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Vicarious Surgical's value of 0.28 is 56.3% below this benchmark. Historically, Vicarious Surgical's own Equity-to-Asset has ranged from 0.05 to 0.95 over the past decade. While the company's 10-year median is 0.72 vs. the industry median of 0.64, Vicarious Surgical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vicarious Surgical's current Equity-to-Asset of 0.28 is 56.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Vicarious Surgical and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vicarious Surgical's current Equity-to-Asset is 0.28, which is 61% below median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicarious Surgical stock overvalued right now?
Vicarious Surgical (RBOT) has a current Equity-to-Asset of 0.28. The current Equity-to-Asset is 0.28, which is 61% below median its 10-year median of 0.72 and 56.3% below the Medical Devices & Instruments industry median of 0.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Vicarious Surgical (RBOT), the current Equity-to-Asset is 0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vicarious Surgical Inc is combining miniaturized robotics, computer science, sensing and 3D visualization to build a new category of intelligent and affordable single-port surgical robots that virtually transport surgeons inside the patient to perform minimally invasive surgery. Its single-port surgical robot, called the Vicarious Surgical System is being developed to provide attractive advantages to hospitals and ambulatory surgical centers, or ASCs, which it believes will drive rapid and widespread adoption. The company operates as one operating segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RBOT has been successfully added to your 
